Arcus Biosciences (RCUS)
24.07
-0.52 (2.11%)
Upcoming Events
Latest Headlines
Arcus Biosciences (RCUS) Reiterated at Overweight by Cantor Fitzgerald After CFO Chat
September 11, 2026 7:03 AM - StreetInsider
Arcus Biosciences Announces New Employment Inducement Grants
September 9, 2026 4:35 PM - BizWire
Arcus Biosciences (RCUS) PT Raised to $40 at Truist Securities
September 8, 2026 7:15 AM - StreetInsider
Arcus Biosciences to Participate in Three Upcoming Investor Conferences
August 26, 2026 4:05 PM - BizWire
Form 4 Arcus Biosciences, Inc. For: Aug 21 Filed by: Azoy Alexander
August 24, 2026 5:52 PM - SEC Filing
Form 144 Arcus Biosciences, Inc. Filed by: Azoy Alexander
August 21, 2026 4:37 PM - SEC Filing
Arcus Biosciences Announces New Employment Inducement Grants
August 11, 2026 4:35 PM - BizWire
Arcus Biosciences (RCUS) PT Raised to $23 at Morgan Stanley
August 10, 2026 8:35 AM - StreetInsider
Form SCHEDULE 13D/A Arcus Biosciences, Inc. Filed by: GILEAD SCIENCES, INC.
August 7, 2026 4:30 PM - SEC Filing
Arcus Biosciences (RCUS) PT Raised to $26 at Wells Fargo
August 6, 2026 6:38 AM - StreetInsider
Arcus Biosciences (RCUS) Tops Q2 EPS by 18c
August 5, 2026 4:51 PM - StreetInsider
Form 10-Q Arcus Biosciences, Inc. For: Jun 30
August 5, 2026 4:16 PM - SEC Filing
Form 8-K Arcus Biosciences, Inc. For: Aug 05
August 5, 2026 4:11 PM - SEC Filing
Arcus Biosciences Reports Second-Quarter 2026 Financial Results and Provides a Pipeline Update
August 5, 2026 4:05 PM - BizWire
Arcus Biosciences Announces New Employment Inducement Grants
July 27, 2026 4:35 PM - BizWire
H.C. Wainwright Reiterates Buy Rating on Arcus Biosciences (RCUS)
July 23, 2026 7:11 AM - StreetInsider
Arcus, AVEO to test kidney cancer drug combo in new trial
July 22, 2026 4:35 PM - StreetInsider
Arcus Biosciences Announces Clinical Supply Agreement with AVEO Oncology to Evaluate Casdatifan in Combination with Tivozanib for Advanced Kidney Cancer Patients
July 22, 2026 4:35 PM - BizWire
Arcus and Summit team up to test kidney cancer drug combo
July 22, 2026 4:30 PM - StreetInsider
Arcus Biosciences and Summit Therapeutics Enter Into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer
July 22, 2026 4:30 PM - BizWire
Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2026 Financial Results and Pipeline Updates
July 21, 2026 4:05 PM - BizWire
Arcus Biosciences (RCUS) PT Raised to $45 at H.C. Wainwright
July 20, 2026 6:47 AM - StreetInsider
Form 144 Arcus Biosciences, Inc. Filed by: Jaen Juan C.
July 15, 2026 11:53 AM - SEC Filing
Form 4 Arcus Biosciences, Inc. For: Jul 09 Filed by: Jaen Juan C.
July 13, 2026 5:37 PM - SEC Filing
Form 144 Arcus Biosciences, Inc. Filed by: Jaen Juan C.
July 9, 2026 6:31 PM - SEC Filing
Arcus Biosciences Announces New Employment Inducement Grants
July 9, 2026 4:35 PM - BizWire
Arcus kidney cancer drug data published in Nature journal
July 1, 2026 11:00 AM - StreetInsider
New Research Published in Nature Links Clinical Activity with HIF‑2a Biology in Advanced Kidney Cancer Patients Treated with Casdatifan
July 1, 2026 11:00 AM - BizWire
Form 144 Arcus Biosciences, Inc. Filed by: Jaen Juan C.
June 24, 2026 6:18 PM - SEC Filing
Form 4 Arcus Biosciences, Inc. For: Jun 22 Filed by: Jaen Juan C.
June 24, 2026 5:42 PM - SEC Filing
Arcus Biosciences Announces New Employment Inducement Grants
June 24, 2026 4:35 PM - BizWire
Form 144 Arcus Biosciences, Inc. Filed by: Jaen Juan C.
June 22, 2026 6:31 PM - SEC Filing
Full Article List
